JP2016525343A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016525343A5 JP2016525343A5 JP2016517056A JP2016517056A JP2016525343A5 JP 2016525343 A5 JP2016525343 A5 JP 2016525343A5 JP 2016517056 A JP2016517056 A JP 2016517056A JP 2016517056 A JP2016517056 A JP 2016517056A JP 2016525343 A5 JP2016525343 A5 JP 2016525343A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- seq
- sequence
- antibiotic
- conjugate compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361829466P | 2013-05-31 | 2013-05-31 | |
| US201361829461P | 2013-05-31 | 2013-05-31 | |
| US61/829,466 | 2013-05-31 | ||
| US61/829,461 | 2013-05-31 | ||
| USPCT/US2014/039113 | 2014-05-22 | ||
| US14/284,609 | 2014-05-22 | ||
| US14/284,609 US20140356375A1 (en) | 2013-05-31 | 2014-05-22 | Anti-wall teichoic antibodies and conjugates |
| PCT/US2014/039113 WO2014193722A1 (en) | 2013-05-31 | 2014-05-22 | Anti-wall teichoic antibodies and conjugates |
| PCT/US2014/040324 WO2014194247A1 (en) | 2013-05-31 | 2014-05-30 | Anti-wall teichoic antibodies and conjugates |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018208440A Division JP2019054801A (ja) | 2013-05-31 | 2018-11-05 | 抗細胞壁タイコ酸抗体及びコンジュゲート |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016525343A JP2016525343A (ja) | 2016-08-25 |
| JP2016525343A5 true JP2016525343A5 (enExample) | 2018-06-14 |
| JP6469094B2 JP6469094B2 (ja) | 2019-02-13 |
Family
ID=51989438
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016517056A Expired - Fee Related JP6469094B2 (ja) | 2013-05-31 | 2014-05-30 | 抗細胞壁タイコ酸抗体及びコンジュゲート |
| JP2018208440A Pending JP2019054801A (ja) | 2013-05-31 | 2018-11-05 | 抗細胞壁タイコ酸抗体及びコンジュゲート |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018208440A Pending JP2019054801A (ja) | 2013-05-31 | 2018-11-05 | 抗細胞壁タイコ酸抗体及びコンジュゲート |
Country Status (30)
| Country | Link |
|---|---|
| EP (2) | EP3004162B1 (enExample) |
| JP (2) | JP6469094B2 (enExample) |
| KR (1) | KR20160015227A (enExample) |
| CN (2) | CN105358573B (enExample) |
| AU (2) | AU2014273939B2 (enExample) |
| BR (1) | BR112015029838A2 (enExample) |
| CA (1) | CA2910029A1 (enExample) |
| CL (1) | CL2015003496A1 (enExample) |
| CR (1) | CR20150626A (enExample) |
| DK (1) | DK3004162T3 (enExample) |
| EA (1) | EA201592078A1 (enExample) |
| ES (1) | ES2793174T3 (enExample) |
| HK (1) | HK1220982A1 (enExample) |
| HR (1) | HRP20200812T1 (enExample) |
| HU (1) | HUE050451T2 (enExample) |
| IL (1) | IL242175B (enExample) |
| LT (1) | LT3004162T (enExample) |
| MA (1) | MA38686A1 (enExample) |
| MX (2) | MX369022B (enExample) |
| MY (1) | MY177774A (enExample) |
| PE (1) | PE20160715A1 (enExample) |
| PH (1) | PH12015502636A1 (enExample) |
| PL (1) | PL3004162T3 (enExample) |
| PT (1) | PT3004162T (enExample) |
| RS (1) | RS60256B1 (enExample) |
| SG (1) | SG11201509839TA (enExample) |
| SI (1) | SI3004162T1 (enExample) |
| UA (1) | UA120088C2 (enExample) |
| WO (1) | WO2014194247A1 (enExample) |
| ZA (1) | ZA201507977B (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX369758B (es) | 2013-05-31 | 2019-11-20 | Genentech Inc | Anticuerpos anti-acido teicoico de pared y conjugados. |
| BR112016014126B1 (pt) | 2013-12-16 | 2023-02-14 | Medimmune Limited | Composto não-peptídico, conjugados de anticorpo-fármaco do mesmo, uso dos ditos conjugados para o tratamento de câncer e composição farmacêutica que compreende os mesmos |
| UA118113C2 (uk) | 2013-12-16 | 2018-11-26 | Дженентек, Інк. | Пептидоміметичні сполуки та їх кон'югати антитіла з лікарським засобом |
| HRP20241124T1 (hr) * | 2014-09-11 | 2024-11-22 | Seagen Inc. | Ciljana isporuka lijekovitih tvari koje sadrže tercijarni amin |
| KR20170086536A (ko) | 2014-12-03 | 2017-07-26 | 제넨테크, 인크. | 항-스타필로코커스 아우레우스 항체 리파마이신 접합체 및 이의 용도 |
| CA2969689A1 (en) * | 2014-12-03 | 2016-06-09 | Genentech, Inc. | Quaternary amine compounds and antibody-drug conjugates thereof |
| MX2017007231A (es) | 2014-12-03 | 2017-11-08 | Genentech Inc | Conjugados de rifamicina y anticuerpos contra el staphylococcuss aureus y usos de estos. |
| US10017577B2 (en) | 2015-06-15 | 2018-07-10 | Genentech, Inc. | Antibodies and immunoconjugates |
| US11229708B2 (en) | 2015-12-04 | 2022-01-25 | Seagen Inc. | Conjugates of quaternized tubulysin compounds |
| US11793880B2 (en) | 2015-12-04 | 2023-10-24 | Seagen Inc. | Conjugates of quaternized tubulysin compounds |
| BR112018014355A2 (pt) * | 2016-03-04 | 2018-12-18 | Genentech, Inc. | processos para a preparação de f-benzoxazinorifamicina i e para a preparação de 2-amino-5-fluorobenzeno-1,3-diol iii |
| JP2019519509A (ja) * | 2016-05-18 | 2019-07-11 | ゲンマブ ビー．ブイ． | 感染性疾患の治療における抗体およびその使用方法 |
| JP7043425B2 (ja) | 2016-06-06 | 2022-03-29 | ジェネンテック， インコーポレイテッド | シルベストロール抗体－薬物コンジュゲート及び使用方法 |
| MA50124A (fr) | 2017-09-08 | 2020-07-15 | Seattle Genetics Inc | Procédé de préparation de tubulysines et d'intermédiaires de celles-ci |
| US11857638B2 (en) | 2018-07-27 | 2024-01-02 | Promega Corporation | Quinone-containing conjugates |
| WO2021195716A1 (en) * | 2020-04-02 | 2021-10-07 | Monash University | Antibiotic conjugates |
| GB202214756D0 (en) * | 2022-10-07 | 2022-11-23 | Univ Oxford Innovation Ltd | Product |
Family Cites Families (70)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB877732A (en) | 1958-08-12 | 1961-09-20 | Lepetit Spa | The antibiotic rifomycin, its components and methods of preparing same |
| US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| US4485045A (en) | 1981-07-06 | 1984-11-27 | Research Corporation | Synthetic phosphatidyl cholines useful in forming liposomes |
| US4867973A (en) * | 1984-08-31 | 1989-09-19 | Cytogen Corporation | Antibody-therapeutic agent conjugates |
| DD266710A3 (de) | 1983-06-06 | 1989-04-12 | Ve Forschungszentrum Biotechnologie | Verfahren zur biotechnischen Herstellung van alkalischer Phosphatase |
| US4544545A (en) | 1983-06-20 | 1985-10-01 | Trustees University Of Massachusetts | Liposomes containing modified cholesterol for organ targeting |
| US4879231A (en) | 1984-10-30 | 1989-11-07 | Phillips Petroleum Company | Transformation of yeasts of the genus pichia |
| US4737456A (en) | 1985-05-09 | 1988-04-12 | Syntex (U.S.A.) Inc. | Reducing interference in ligand-receptor binding assays |
| US4610919A (en) | 1985-06-14 | 1986-09-09 | Fiber Bond Corporation | Binder for fibrous padding |
| GB8610600D0 (en) | 1986-04-30 | 1986-06-04 | Novo Industri As | Transformation of trichoderma |
| JP2544375B2 (ja) | 1986-07-14 | 1996-10-16 | 鐘淵化学工業株式会社 | アルキル置換ベンゾキサジノリフアマイシン誘導体 |
| IL85035A0 (en) | 1987-01-08 | 1988-06-30 | Int Genetic Eng | Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same |
| CA1304363C (en) | 1988-11-01 | 1992-06-30 | Takehiko Yamane | 3'-hydroxybenzoxazinorifamycin derivative, process for preparing the same and antibacterial agent containing the same |
| EP0402226A1 (en) | 1989-06-06 | 1990-12-12 | Institut National De La Recherche Agronomique | Transformation vectors for yeast yarrowia |
| US5013556A (en) | 1989-10-20 | 1991-05-07 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| EP0590058B1 (en) | 1991-06-14 | 2003-11-26 | Genentech, Inc. | HUMANIZED Heregulin ANTIBODy |
| US5362852A (en) | 1991-09-27 | 1994-11-08 | Pfizer Inc. | Modified peptide derivatives conjugated at 2-hydroxyethylamine moieties |
| US5545721A (en) | 1992-12-21 | 1996-08-13 | Ophidian Pharmaceuticals, Inc. | Conjugates for the prevention and treatment of sepsis |
| US6660267B1 (en) | 1992-12-21 | 2003-12-09 | Promega Corporation | Prevention and treatment of sepsis |
| US6214345B1 (en) | 1993-05-14 | 2001-04-10 | Bristol-Myers Squibb Co. | Lysosomal enzyme-cleavable antitumor drug conjugates |
| US6214388B1 (en) | 1994-11-09 | 2001-04-10 | The Regents Of The University Of California | Immunoliposomes that optimize internalization into target cells |
| US5981522A (en) | 1995-09-01 | 1999-11-09 | Kaneka Corporation | Treatment of disease caused by infection of Helicobacter |
| JP3963976B2 (ja) | 1995-12-08 | 2007-08-22 | 株式会社カネカ | クラミジア感染症治療剤 |
| US6322788B1 (en) | 1998-08-20 | 2001-11-27 | Stanley Arthur Kim | Anti-bacterial antibodies and methods of use |
| EP2275540B1 (en) | 1999-04-09 | 2016-03-23 | Kyowa Hakko Kirin Co., Ltd. | Method for controlling the activity of immunologically functional molecule |
| JP2003503015A (ja) | 1999-05-03 | 2003-01-28 | メダレツクス・インコーポレーテツド | スタフィロコッカス・アウレウスに対するヒト抗体 |
| CA2388245C (en) | 1999-10-19 | 2012-01-10 | Kyowa Kirin Co., Ltd. | The use of serum-free adapted rat cells for producing heterologous polypeptides |
| US6946292B2 (en) | 2000-10-06 | 2005-09-20 | Kyowa Hakko Kogyo Co., Ltd. | Cells producing antibody compositions with increased antibody dependent cytotoxic activity |
| US7064191B2 (en) | 2000-10-06 | 2006-06-20 | Kyowa Hakko Kogyo Co., Ltd. | Process for purifying antibody |
| CN103333860B (zh) | 2000-10-06 | 2015-07-08 | 协和发酵麒麟株式会社 | 产生抗体组合物的细胞 |
| US6884869B2 (en) | 2001-04-30 | 2005-04-26 | Seattle Genetics, Inc. | Pentapeptide compounds and uses related thereto |
| WO2003026577A2 (en) | 2001-09-24 | 2003-04-03 | Seattle Genetics, Inc. | P-amidobenzylethers in drug delivery agents |
| US7091186B2 (en) | 2001-09-24 | 2006-08-15 | Seattle Genetics, Inc. | p-Amidobenzylethers in drug delivery agents |
| PL213948B1 (pl) | 2001-10-25 | 2013-05-31 | Genentech Inc | Kompozycje zawierajace glikoproteine, czasteczka kwasu nukleinowego kodujaca te glikoproteine, komórka gospodarza, sposób wytwarzania glikoproteiny, kompozycja do zastosowania do leczenia, zastosowanie kompozycji i zestaw zawierajacy kompozycje |
| US20050123536A1 (en) | 2001-11-20 | 2005-06-09 | Che-Leung Law | Treatment of immunological disorders using anti-dc30 antibodies |
| US20040093621A1 (en) | 2001-12-25 | 2004-05-13 | Kyowa Hakko Kogyo Co., Ltd | Antibody composition which specifically binds to CD20 |
| KR20050000380A (ko) | 2002-04-09 | 2005-01-03 | 교와 핫꼬 고교 가부시끼가이샤 | 게놈이 개변된 세포 |
| EP1498490A4 (en) | 2002-04-09 | 2006-11-29 | Kyowa Hakko Kogyo Kk | PROCESS FOR PREPARING ANTIBODY COMPOSITION |
| WO2003085102A1 (en) | 2002-04-09 | 2003-10-16 | Kyowa Hakko Kogyo Co., Ltd. | Cell with depression or deletion of the activity of protein participating in gdp-fucose transport |
| WO2003084570A1 (en) | 2002-04-09 | 2003-10-16 | Kyowa Hakko Kogyo Co., Ltd. | DRUG CONTAINING ANTIBODY COMPOSITION APPROPRIATE FOR PATIENT SUFFERING FROM FcϜRIIIa POLYMORPHISM |
| EP1498491A4 (en) | 2002-04-09 | 2006-12-13 | Kyowa Hakko Kogyo Kk | METHOD FOR INCREASING THE ACTIVITY OF AN ANTIBODY COMPOSITION FOR BINDING TO THE FC GAMMA RECEPTOR IIIA |
| CA2481920A1 (en) | 2002-04-09 | 2003-10-16 | Kyowa Hakko Kogyo Co., Ltd. | Antibody composition-containing medicament |
| CA2494104A1 (en) | 2002-07-31 | 2004-04-22 | Seattle Genetics, Inc. | Anti-cd20 antibody-drug conjugates for the treatment of cancer and immune disorders |
| ES2369542T3 (es) | 2002-07-31 | 2011-12-01 | Seattle Genetics, Inc. | Conjugados de auristatina y su uso para tratar cáncer, una enfermedad autoinmune o una enfermedad infecciosa. |
| US7217797B2 (en) | 2002-10-15 | 2007-05-15 | Pdl Biopharma, Inc. | Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis |
| WO2004042072A2 (en) | 2002-11-01 | 2004-05-21 | The Regents Of The University Of Colorado, A Body Corporate | Quantitative analysis of protein isoforms using matrix-assisted laser desorption/ionization time of flight mass spectrometry |
| EP1567868A4 (en) * | 2002-12-02 | 2008-02-06 | Biosynexus Inc | CELL WALL TEICHONSURE AS A GOAL F RANTI-STAPHYLOCOCCUS THERAPIES AND VACCINATES |
| HUE035898T2 (en) | 2002-12-16 | 2018-05-28 | Genentech Inc | Immunoglobulin variants and their applications |
| MXPA06002088A (es) | 2003-08-22 | 2006-08-11 | Activbiotics Inc | Analogos de rifamicina y usos de los mismos. |
| JPWO2005035586A1 (ja) | 2003-10-08 | 2007-11-22 | 協和醗酵工業株式会社 | 融合蛋白質組成物 |
| CA2542125A1 (en) | 2003-10-09 | 2005-04-21 | Kyowa Hakko Kogyo Co., Ltd. | Process for producing antibody composition by using rna inhibiting the function of .alpha.1,6-fucosyltransferase |
| ES2605443T3 (es) | 2003-11-06 | 2017-03-14 | Seattle Genetics, Inc. | Conjugados de auristatina con anticuerpos anti-HER2 o anti-CD22 y su uso en terapia |
| JPWO2005053742A1 (ja) | 2003-12-04 | 2007-06-28 | 協和醗酵工業株式会社 | 抗体組成物を含有する医薬 |
| CN1918172B (zh) | 2003-12-23 | 2011-09-14 | 活跃生物工艺学公司 | 利福霉素类似物及其用途 |
| CA2556752C (en) | 2004-02-23 | 2016-02-02 | Genentech, Inc. | Heterocyclic self-immolative linkers and conjugates |
| TR201808537T4 (tr) | 2004-09-23 | 2018-07-23 | Genentech Inc | Sistein değiştirilmiş antikorlar ve konjugatlar. |
| WO2007008848A2 (en) | 2005-07-07 | 2007-01-18 | Seattle Genetics, Inc. | Monomethylvaline compounds having phenylalanine carboxy modifications at the c-terminus |
| ES2708763T3 (es) | 2005-07-07 | 2019-04-11 | Seattle Genetics Inc | Compuestos de monometilvalina que tienen modificaciones de la cadena lateral de fenilalanina en el extremo C |
| US8404664B2 (en) * | 2005-08-11 | 2013-03-26 | Targanta Therapeutics, Inc. | Phosphonated Rifamycins and uses thereof for the prevention and treatment of bone and joint infections |
| MX2008007808A (es) | 2005-12-14 | 2008-09-15 | Activbiotics Pharma Llc | Analogos de rifamicina y usos de ellos. |
| NZ578851A (en) | 2007-03-01 | 2011-09-30 | Symphogen As | Method for cloning cognate antibodies |
| PE20090245A1 (es) | 2007-05-08 | 2009-03-17 | Genentech Inc | Anticuerpos anti-muc16 disenados con cisteina y conjugados de anticuerpos y farmacos |
| BRPI0818780A2 (pt) | 2007-10-19 | 2015-04-22 | Genentech Inc | Anticorpo anti-tenb2 planejados por cisteína e conjugados de medicamento com anticorpos |
| WO2009140236A2 (en) | 2008-05-12 | 2009-11-19 | Strox Biopharmaceuticals, Llc | Staphylococcus aureus-specific antibody preparations |
| US8524691B2 (en) | 2008-08-13 | 2013-09-03 | The Medicines Company | Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections |
| US20110262477A1 (en) | 2008-10-06 | 2011-10-27 | University Of Chicago | Compositions and Methods Related to Bacterial EAP, EMP, and/or ADSA Proteins |
| CN102666583B (zh) * | 2009-07-15 | 2015-11-25 | Aimm医疗股份公司 | 革兰氏阳性细菌特异性结合化合物 |
| CA3220104A1 (en) | 2010-06-08 | 2011-12-15 | Genentech, Inc. | Cysteine engineered antibodies and conjugates |
| EP2678037B1 (en) | 2011-02-25 | 2014-12-03 | Lonza Ltd | Branched linker for protein drug conjugates |
| KR20150024315A (ko) * | 2012-05-07 | 2015-03-06 | 재단법인 목암생명공학연구소 | 포도상구균 감염 예방용 백신 조성물 |
-
2014
- 2014-05-30 PE PE2015002538A patent/PE20160715A1/es unknown
- 2014-05-30 PL PL14732800T patent/PL3004162T3/pl unknown
- 2014-05-30 PT PT147328009T patent/PT3004162T/pt unknown
- 2014-05-30 MX MX2015016405A patent/MX369022B/es active IP Right Grant
- 2014-05-30 CN CN201480037322.1A patent/CN105358573B/zh not_active Expired - Fee Related
- 2014-05-30 JP JP2016517056A patent/JP6469094B2/ja not_active Expired - Fee Related
- 2014-05-30 HK HK16109071.5A patent/HK1220982A1/zh unknown
- 2014-05-30 DK DK14732800.9T patent/DK3004162T3/da active
- 2014-05-30 BR BR112015029838A patent/BR112015029838A2/pt not_active Application Discontinuation
- 2014-05-30 WO PCT/US2014/040324 patent/WO2014194247A1/en not_active Ceased
- 2014-05-30 SI SI201431578T patent/SI3004162T1/sl unknown
- 2014-05-30 MA MA38686A patent/MA38686A1/fr unknown
- 2014-05-30 KR KR1020157033622A patent/KR20160015227A/ko not_active Ceased
- 2014-05-30 MY MYPI2015002849A patent/MY177774A/en unknown
- 2014-05-30 EP EP14732800.9A patent/EP3004162B1/en not_active Not-in-force
- 2014-05-30 UA UAA201511604A patent/UA120088C2/uk unknown
- 2014-05-30 HU HUE14732800A patent/HUE050451T2/hu unknown
- 2014-05-30 AU AU2014273939A patent/AU2014273939B2/en not_active Ceased
- 2014-05-30 CA CA2910029A patent/CA2910029A1/en not_active Abandoned
- 2014-05-30 ES ES14732800T patent/ES2793174T3/es active Active
- 2014-05-30 EP EP18169959.6A patent/EP3381939A1/en not_active Withdrawn
- 2014-05-30 LT LTEP14732800.9T patent/LT3004162T/lt unknown
- 2014-05-30 CN CN202011074088.3A patent/CN112430266A/zh active Pending
- 2014-05-30 HR HRP20200812TT patent/HRP20200812T1/hr unknown
- 2014-05-30 EA EA201592078A patent/EA201592078A1/ru unknown
- 2014-05-30 SG SG11201509839TA patent/SG11201509839TA/en unknown
- 2014-05-30 RS RS20200548A patent/RS60256B1/sr unknown
-
2015
- 2015-10-20 IL IL242175A patent/IL242175B/en active IP Right Grant
- 2015-10-27 ZA ZA2015/07977A patent/ZA201507977B/en unknown
- 2015-11-25 CR CR20150626A patent/CR20150626A/es unknown
- 2015-11-26 PH PH12015502636A patent/PH12015502636A1/en unknown
- 2015-11-27 MX MX2019012708A patent/MX2019012708A/es unknown
- 2015-11-30 CL CL2015003496A patent/CL2015003496A1/es unknown
-
2018
- 2018-11-05 JP JP2018208440A patent/JP2019054801A/ja active Pending
-
2019
- 2019-12-11 AU AU2019279986A patent/AU2019279986A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2023078021A1 (en) | Bcma monoclonal antibody and the antibody-drug conjugate | |
| RU2015151046A (ru) | Антитела против стеночной тейхоевой кислоты и их конъюгаты | |
| RU2017118793A (ru) | Конъюгаты антитела к staphylococcus aureus с рифамицином и их применение | |
| JP2018503603A5 (enExample) | ||
| RU2017118792A (ru) | Конъюгаты антитела к staphylococcus aureus с рифамицином и их применение | |
| CN113423430B (zh) | 含支链连接子的鹅膏毒素偶联物 | |
| CN109912683B (zh) | 一种细胞毒素分子、偶联物及其制备方法和应用 | |
| JP2018507166A5 (enExample) | ||
| KR20230034957A (ko) | 캄프토테신 유사체를 갖는 세포-결합 분자의 접합체 | |
| HRP20200812T1 (hr) | Protutijela protiv teihonske kiseline staničnog zida i konjugati | |
| HRP20221280T1 (hr) | Spojevi i njihovi konjugati | |
| TW202108179A (zh) | 細胞毒性劑經由支鏈連接子與細胞結合分子的偶聯物 | |
| WO2024239281A1 (en) | Targeted treatment of prostate cancers and other tumors by an antibody-drug conjugate | |
| JP2017528418A5 (enExample) | ||
| CN111093707A (zh) | 含支链连接体的Tubulysin同系物偶联物 | |
| CN116143678A (zh) | 偶联连接体，含有此连接体的细胞结合分子-药物偶联物及其制备和应用 | |
| EP3086814A1 (de) | Binder-konjugate (adcs) mit ksp-inhibitoren | |
| CN112272669A (zh) | 横交联吡咯并苯二氮杂*二聚体（pbd）衍生物及其偶联物 | |
| AU2016202632A1 (en) | Specific conjugation linkers, specific immunoconjugates thereof, methods of making and uses such conjugates thereof | |
| RU2016129894A (ru) | Ковалентно связанные конъюгаты хеликар-антитело против хеликара и их применения | |
| CN110279872A (zh) | 细胞毒素分子同细胞结合受体分子的共轭体 | |
| EA053258B1 (ru) | Конъюгат аматоксинового аналога с разветвленными линкерами | |
| HRP20201293T1 (hr) | Citotoksični derivati benzodiazepina | |
| EA048944B1 (ru) | Сшитое производное димера пирролобензодиазепина (pbd) и его конъюгаты |